Suchergebnisse - "Lim, Chay Ngee"

PubPharm (2)

1

Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes : 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249

enthalten in: Diabetes care | 2016

von Kazda, C. | Ding, Y. | Kelly, R. | +10

CommentOn: Diabetes Care. 2016 Jul;39(7):1241-9. - PMID 26681715

2

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes : 12- and 24-Week Phase 2 Studies

enthalten in: Diabetes care | 2016

von Kazda, C. | Ding, Y. | Kelly, R. | +10

CommentIn: Diabetes Care. 2016 Jul;39(7):1075-7. - PMID 27330122

1
[1]